突变的p53再激活剂保护乳腺癌细胞免受铁灭
Dewmi Sandaru Rathnayake1, Samkeliso Dlamini2, Kadry Elkalawozgy1
1Department of Biological Sciences, University of Toledo, Toledo, Ohio, USA.
Cell biochemistry and function
|May 23, 2024
概括
某些旨在重新激活瘤抑制剂p53的癌症药物惊人地保护细胞免受ferroptosis,一种细胞死亡形式. 这种保护作用是独立于p53发生的,这表明了抗癌进展的新机制.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 铁亡是一种受调节的细胞死亡途径,由依赖铁的脂质过氧化驱动.
- 瘤抑制剂p53通常使细胞对铁亡敏感,但p53在癌症中经常丢失或发生突变.
- 存在小分子来重新激活突变p53,这对癌症治疗有潜在的影响.
研究的目的:
- 为了研究p53反应器是否可以增强癌细胞对铁亡的敏感性.
- 探索p53活性剂影响铁亡的机制.
主要方法:
- 用 p53 反激活剂和铁灭诱导剂治疗癌细胞系.
- 评估细胞活力和细胞死亡途径.
- 对活性氧物种和谷氨过氧化酶4 (GPX4) 水平的分析.
主要成果:
- 几种p53反应激活剂出乎意料地保护细胞免受铁灭.
- 这种保护甚至在p53-null癌细胞中也被观察到.
- 保护作用并不是由于自由基清除或铁化.
- 一种化合物NSC 59984降低了GPX4的表达,但这并不能解释观察到的铁灭菌耐药性.
结论:
- 通过一个独立于p53的机制,p53活性剂可以抑制铁亡.
- 这些发现揭示了p53再激活剂在调节细胞死亡途径中的新作用.
- 需要进一步的研究来阐明这些化合物抑制铁亡的确切机制.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K


